 Check-Cap Ltd. the Company or Check-Cap NASDAQ: CHEK, NASDAQ: CHEKZ, a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only preparation-free screening test to detect polyps before they transform into colorectal cancer, today provided an update on the impact of the global COVID-19 coronavirus pandemic on the Companys operational and clinical activities. 